Skip to main content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

30.12.2022 | Originalien

Hormonpumpen

verfasst von: Birgit Reinhart-Steininger, Ingrid Schütz-Fuhrmann, Thomas M. Stulnig

Erschienen in: Journal für Klinische Endokrinologie und Stoffwechsel

Einloggen, um Zugang zu erhalten
share
TEILEN

Zusammenfassung

Medizinische Pumpensysteme ermöglichen die akkurate Gabe eines Medikaments in Form einer kontinuierlichen Infusion und/oder rezidivierenden Bolusgabe über einen Katheter in das subkutane Fettgewebe, nach intravenös oder auch intrathekal. Sie erleichtern den Alltag der PatientInnen, da andernfalls die häufige Selbstinjektion des Medikaments notwendig wäre, was nicht nur schmerzbehaftet sein kann, sondern tagsüber sowie unter Umständen auch nachts eine aktive Handlung des Patienten erfordert. Darüber hinaus können Hormonpumpen den physiologischen Stoffwechselprozess oft besser nachahmen, was für manche endokrine Erkrankungen eine Behandlung überhaupt erst ermöglicht. In diesem Review konzentrieren wir uns auf die Hauptanwendungsgebiete subkutaner Hormonpumpensysteme, nämlich den Diabetes mellitus Typ 1 (T1DM) sowie Anwendungen in der Gynäkologie und Reproduktionsmedizin, insbesondere bei hypothalamischer Insuffizienz.
Literatur
1.
Zurück zum Zitat Ostrovski I et al (2020) Analysis of prevalence, magnitude and timing of the dawn phenomenon in adults and adolescents with type 1 diabetes: descriptive analysis of 2 insulin pump trials. Can J Diabetes 44:229 CrossRef Ostrovski I et al (2020) Analysis of prevalence, magnitude and timing of the dawn phenomenon in adults and adolescents with type 1 diabetes: descriptive analysis of 2 insulin pump trials. Can J Diabetes 44:229 CrossRef
2.
Zurück zum Zitat Thomas A (2010) Diabetes und Technologie, Geschichte der Insulinpumpentherapie Thomas A (2010) Diabetes und Technologie, Geschichte der Insulinpumpentherapie
5.
Zurück zum Zitat Ly TT, Nicholas JA, Retterath A et al (2013) Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 310:1240–1247 CrossRef Ly TT, Nicholas JA, Retterath A et al (2013) Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 310:1240–1247 CrossRef
7.
Zurück zum Zitat Bergenstal RM et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224–232 CrossRef Bergenstal RM et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224–232 CrossRef
8.
Zurück zum Zitat Forlenza GP et al (2018) Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care 41:2155–2161 CrossRef Forlenza GP et al (2018) Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care 41:2155–2161 CrossRef
11.
12.
Zurück zum Zitat Bergenstal RM et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316:1407–1408 CrossRef Bergenstal RM et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316:1407–1408 CrossRef
13.
Zurück zum Zitat Brown SA et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381:1707–1717 CrossRef Brown SA et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381:1707–1717 CrossRef
14.
Zurück zum Zitat Lal RA, Basina M, Maahs DM et al (2019) One year clinical experience of the first commercial hybrid closed-loop system. Diabetes Care 42:2190–2196 CrossRef Lal RA, Basina M, Maahs DM et al (2019) One year clinical experience of the first commercial hybrid closed-loop system. Diabetes Care 42:2190–2196 CrossRef
15.
Zurück zum Zitat Garg SK et al (2017) Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 19:155–163 CrossRef Garg SK et al (2017) Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 19:155–163 CrossRef
17.
Zurück zum Zitat Ekhlaspour L et al (2022) Outcomes in baseline hemoglobin A1C subgroups in the international diabetes closed-loop 18 trial. Diabetes Technol Ther 24(8):588–591 CrossRef Ekhlaspour L et al (2022) Outcomes in baseline hemoglobin A1C subgroups in the international diabetes closed-loop 18 trial. Diabetes Technol Ther 24(8):588–591 CrossRef
20.
Zurück zum Zitat Jennings P, Hussain S (2020) Do-it-yourself artificial pancreas systems: a review of the emerging evidence and insights for healthcare professionals. J Diabetes Sci Technol 14:868–877 CrossRef Jennings P, Hussain S (2020) Do-it-yourself artificial pancreas systems: a review of the emerging evidence and insights for healthcare professionals. J Diabetes Sci Technol 14:868–877 CrossRef
21.
Zurück zum Zitat Braune K, OPEN International Healthcare Professional Network and OPEN Legal Advisory Group et al (2022) Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol 10(1):58–74. https://​doi.​org/​10.​1016/​S2213-8587(21)00267-9 (Erratum in: Lancet Diabetes Endocrinol. 2022 Jan;10(1):e1) CrossRef Braune K, OPEN International Healthcare Professional Network and OPEN Legal Advisory Group et al (2022) Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol 10(1):58–74. https://​doi.​org/​10.​1016/​S2213-8587(21)00267-9 (Erratum in: Lancet Diabetes Endocrinol. 2022 Jan;10(1):e1) CrossRef
23.
Zurück zum Zitat Castellanos LE et al (2021) Performance of the insulin-only ilet bionic pancreas 17 and the bihormonal ilet using dasiglucagon in adults with type 1 diabetes in a home-use 18 setting. Diabetes Care 44(6):e118–e120 CrossRef Castellanos LE et al (2021) Performance of the insulin-only ilet bionic pancreas 17 and the bihormonal ilet using dasiglucagon in adults with type 1 diabetes in a home-use 18 setting. Diabetes Care 44(6):e118–e120 CrossRef
24.
Zurück zum Zitat Haidar A et al (2020) A novel dual-20 hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized 21 controlled crossover trial. Diabetes Care 43(3):597–606 CrossRef Haidar A et al (2020) A novel dual-20 hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized 21 controlled crossover trial. Diabetes Care 43(3):597–606 CrossRef
26.
Zurück zum Zitat Holesh JE et al (2022) Physiology, ovulation. StatPearls, Treasure Island (FL) Holesh JE et al (2022) Physiology, ovulation. StatPearls, Treasure Island (FL)
27.
Zurück zum Zitat Crowley WF Jr et al (1981) Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 52:370–372 CrossRef Crowley WF Jr et al (1981) Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 52:370–372 CrossRef
28.
Zurück zum Zitat Topaloglu AK et al (2009) TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet 41:354–358 CrossRef Topaloglu AK et al (2009) TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet 41:354–358 CrossRef
30.
Zurück zum Zitat Whitlock KE (2005) Origin and development of GnRH neurons. Trends Endocrinol Metab 16:145–151 CrossRef Whitlock KE (2005) Origin and development of GnRH neurons. Trends Endocrinol Metab 16:145–151 CrossRef
31.
Zurück zum Zitat Schwanzel-Fukuda M (1989) Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 6:311–326 CrossRef Schwanzel-Fukuda M (1989) Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 6:311–326 CrossRef
32.
Zurück zum Zitat Soussi-Yanicostas N et al (1998) Anosmin‑1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J Cell Sci 111(19):2953–2965 CrossRef Soussi-Yanicostas N et al (1998) Anosmin‑1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J Cell Sci 111(19):2953–2965 CrossRef
33.
Zurück zum Zitat Caron P et al (1999) Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 84:990–996 CrossRef Caron P et al (1999) Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 84:990–996 CrossRef
34.
Zurück zum Zitat Sykiotis GP et al (2010) Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab 95:3019–3027 CrossRef Sykiotis GP et al (2010) Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab 95:3019–3027 CrossRef
35.
Zurück zum Zitat Ankarberg-Lindgren C et al (2001) Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 86:3039–3044 Ankarberg-Lindgren C et al (2001) Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 86:3039–3044
36.
Zurück zum Zitat Bergadá I, Bergadá C (1995) Long term treatment with low dose testosterone in constitutional delay of growth and puberty: effect on bone age maturation and pubertal progression. J Pediatr Endocrinol Metab 8:117–122 CrossRef Bergadá I, Bergadá C (1995) Long term treatment with low dose testosterone in constitutional delay of growth and puberty: effect on bone age maturation and pubertal progression. J Pediatr Endocrinol Metab 8:117–122 CrossRef
37.
Zurück zum Zitat Balasubramanian R, Crowley WF Jr. (2007) Isolated gonadotropin-releasing hormone (GnRH) deficiency. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (Hrsg) GeneReviews. University of Washington, Seattle Balasubramanian R, Crowley WF Jr. (2007) Isolated gonadotropin-releasing hormone (GnRH) deficiency. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (Hrsg) GeneReviews. University of Washington, Seattle
38.
Zurück zum Zitat Martin KA et al (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129 Martin KA et al (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129
39.
Zurück zum Zitat Suh BY et al (1988) Hypercortisolism in patients with functional hypothalamicamenorrhea. J Clin Endocrinol Metab 66:733–739 CrossRef Suh BY et al (1988) Hypercortisolism in patients with functional hypothalamicamenorrhea. J Clin Endocrinol Metab 66:733–739 CrossRef
41.
Zurück zum Zitat Couzinet B et al (1999) Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 50:229–235 CrossRef Couzinet B et al (1999) Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 50:229–235 CrossRef
42.
Zurück zum Zitat Bomba M et al (2007) Endocrine profiles and neuropsychologic correlates of functional hypothalamic amenorrhea in adolescents. Fertil Steril 87:876–885 CrossRef Bomba M et al (2007) Endocrine profiles and neuropsychologic correlates of functional hypothalamic amenorrhea in adolescents. Fertil Steril 87:876–885 CrossRef
43.
Zurück zum Zitat Golden NH, Carlson JL (2008) The pathophysiology of amenorrhea in the adolescent. Ann N Y Acad Sci 1135:163–178 CrossRef Golden NH, Carlson JL (2008) The pathophysiology of amenorrhea in the adolescent. Ann N Y Acad Sci 1135:163–178 CrossRef
44.
Zurück zum Zitat Gordon CM (2010) Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med 363:365–371 CrossRef Gordon CM (2010) Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med 363:365–371 CrossRef
46.
Zurück zum Zitat Martin KA et al (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129 Martin KA et al (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129
47.
Zurück zum Zitat Dumont A et al (2016) Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Gynecol Endocrinol 32:999–1004 CrossRef Dumont A et al (2016) Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Gynecol Endocrinol 32:999–1004 CrossRef
48.
Zurück zum Zitat Wildt L et al (2019) Pulsatile GnRH-Therapie. In: Diedrich K, Ludwig M, Griesinger G (Hrsg) Reproduktionsmedizin. Springer, Berlin, Heidelberg Wildt L et al (2019) Pulsatile GnRH-Therapie. In: Diedrich K, Ludwig M, Griesinger G (Hrsg) Reproduktionsmedizin. Springer, Berlin, Heidelberg
49.
Zurück zum Zitat Begon S et al (1993) Pulsatile administration of gonadotrophin releasing hormone as a diagnostic tool to distinguish hypothalamic from pituitary hypogonadism following neurosurgery. Hum Reprod 8(2):200–203 CrossRef Begon S et al (1993) Pulsatile administration of gonadotrophin releasing hormone as a diagnostic tool to distinguish hypothalamic from pituitary hypogonadism following neurosurgery. Hum Reprod 8(2):200–203 CrossRef
51.
Zurück zum Zitat Liu Z et al (2015) Effectiveness and safety of pulsatile GnRH pump therapy on female patients with IHH. Zhonghua Yi Xue Za Zhi 95(42):3432–3435 Liu Z et al (2015) Effectiveness and safety of pulsatile GnRH pump therapy on female patients with IHH. Zhonghua Yi Xue Za Zhi 95(42):3432–3435
53.
Zurück zum Zitat Tranoulis A et al (2018) Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril 109:708–719 CrossRef Tranoulis A et al (2018) Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril 109:708–719 CrossRef
54.
Zurück zum Zitat Filicori M et al (1991) Ovulation induction with pulsatile gonadotropin-releasing hormone: technical modalities and clinical perspectives. Fertil Steril 56:1–13 CrossRef Filicori M et al (1991) Ovulation induction with pulsatile gonadotropin-releasing hormone: technical modalities and clinical perspectives. Fertil Steril 56:1–13 CrossRef
56.
Zurück zum Zitat Filicori M et al (1994) Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 79:1215–1220 Filicori M et al (1994) Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 79:1215–1220
61.
Zurück zum Zitat Pitteloud N et al (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4128–4136 CrossRef Pitteloud N et al (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4128–4136 CrossRef
62.
Zurück zum Zitat Rastrelli G et al (2014) Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology 2(6):794–808 CrossRef Rastrelli G et al (2014) Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology 2(6):794–808 CrossRef
Metadaten
Titel
Hormonpumpen
verfasst von
Birgit Reinhart-Steininger
Ingrid Schütz-Fuhrmann
Thomas M. Stulnig
Publikationsdatum
30.12.2022
Verlag
Springer Vienna
Erschienen in
Journal für Klinische Endokrinologie und Stoffwechsel
Print ISSN: 1998-7773
Elektronische ISSN: 1998-7781
DOI
https://doi.org/10.1007/s41969-022-00184-x